Showing results (111-120 of 136) with videos related to
Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humansFabio Broglio, Peter van Koetsveld Pv, Andrea Benso, et al.Clinical Endocrinology|October 12, 2004
Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humansFabio Broglio, Cristina Gottero, Flavia Prodam, et al.Reviews in Endocrine & Metabolic Disorders|October 7, 2020
Expected and paradoxical effects of obesity on cancer treatment responseMarco Gallo, Valerio Adinolfi, Viola Barucca, et al.The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical CarcinomaAlfredo Berruti, Salvatore Grisanti, Alina Pulzer, et al.The Journal of Clinical Endocrinology and Metabolism|May 3, 2025
Reassessing the role of copeptin in emergency department admissions for hypotonic hyponatremiaAlessandro Maria Berton, Emanuele Varaldo, Marco Zavattaro, et al.Clinical Endocrinology|April 28, 2011
Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarismAnnamaria De Bellis, Elena Pane, Giuseppe Bellastella, et al.Frontiers in Endocrinology|October 22, 2021
A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing ScoreMirko Parasiliti-Caprino, Fabio Bioletto, Tommaso Frigerio, et al.European Journal of Endocrinology|April 1, 2022
Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgeryMirko Parasiliti-Caprino, Fabio Bioletto, Chiara Lopez, et al.Biomedicines|June 24, 2022
From SGAP-Model to SGAP-Score: A Simplified Predictive Tool for Post-Surgical Recurrence of PheochromocytomaMirko Parasiliti-Caprino, Fabio Bioletto, Chiara Lopez, et al.European Thyroid Journal|April 8, 2025
Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)Giulia Puliani, Marta Bianchini, Carlotta Giani, et al.Pageof 14